Print this page    •   Back to Web version of article

CROI 2014: The Science and Future of PrEP (Video)

By Barbara Jungwirth

April 14, 2014

Mike Cohen, M.D., Dawn Fukuda, Jonathan Mermin, M.D., M.P.H., Carl Dieffenbach, Ph.D., and Dawn Smith, M.D., M.S., M.P.H., sit down to talk about the history of pre-exposure prophylaxis (PrEP), the challenges of implementing current PrEP options and new approaches. The panelists also discuss how to overcome adherence and access issues, provider unease with prescribing the medication, as well as how to move people toward behavioral change so they can be taken off the drug.

Other issues explored include new approaches to longer-acting medication-based prophylaxis, such as monthly injectable drugs and broadly neutralizing antibodies, the use of circumcision as a prevention tool, and the development of other forms of non-behavioral prevention, such as topical agents.

Watch the video to learn more:

More on the panelists:

The video above has been posted on with permission from our partners at the International Foundation for Alternative Research in AIDS (IFARA). Visit IFARA's website or YouTube channel to watch more video interviews from the conference, as well as earlier meetings.

Barbara Jungwirth is a freelance writer and translator based in New York.

Follow Barbara on Twitter: @reliabletran.

Copyright © 2014 Remedy Health Media, LLC. All rights reserved.

This article was provided by It is a part of the publication The 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014). You can find this article online by typing this address into your Web browser:

General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.